Your search returned 47 results.

Results
	41.	Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. [electronic resource] by Maurer, C Langerbeins, P Bahlo, J Cramer, P Fink, A M Pflug, N Engelke, A von Tresckow, J Kovacs, G Stilgenbauer, S Wendtner, C-M Müller, L Ritgen, M Seiler, T Fischer, K Hallek, M Eichhorst, B Producer: 20170807 In: Leukemia vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. [electronic resource] by Al-Sawaf, O Robrecht, S Bahlo, J Fink, A M Cramer, P V Tresckow, J Lange, E Kiehl, M Dreyling, M Ritgen, M Dürig, J Tausch, E Schneider, C Stilgenbauer, S Wendtner, C M Fischer, K Hallek, M Eichhorst, B Producer: 20210113 In: Leukemia vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial. [electronic resource] by Edelmann, J Tausch, E Landau, D A Robrecht, S Bahlo, J Fischer, K Fink, A M Bloehdorn, J Holzmann, K Böttcher, S Werner, L Kneba, M Gribben, J G Neuberg, D S Wu, C J Hallek, M Döhner, H Stilgenbauer, S Producer: 20170929 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	44.	Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia. [electronic resource] by Elter, T James, R Busch, R Winkler, D Ritgen, M Böttcher, S Kahl, C Gassmann, W Stauch, M Hasan, I Staib, P Fischer, K Fink, A-M Bahlo, J Bühler, A Döhner, H Wendtner, C-M Stilgenbauer, S Engert, A Hallek, M Producer: 20130212 In: Leukemia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. [electronic resource] by Fink, A M Böttcher, S Ritgen, M Fischer, K Pflug, N Eichhorst, B Wendtner, C-M Winkler, D Bühler, A Zenz, T Staib, P Mayer, J Hensel, M Hopfinger, G Wenger, M Fingerle-Rowson, G Döhner, H Kneba, M Stilgenbauer, S Busch, R Hallek, M Producer: 20131021 In: Leukemia vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group. [electronic resource] by Al-Sawaf, O Robrecht, S Bahlo, J Fink, A M Cramer, P von Tresckow, J Maurer, C Bergmann, M Seiler, T Lange, E Kneba, M Stilgenbauer, S Döhner, H Kiehl, M G Jäger, U Wendtner, C M Fischer, K Goede, V Hallek, M Eichhorst, B Hopfinger, G Producer: 20180601 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	47.	Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. [electronic resource] by Hallek, M Fischer, K Fingerle-Rowson, G Fink, A M Busch, R Mayer, J Hensel, M Hopfinger, G Hess, G von Grünhagen, U Bergmann, M Catalano, J Zinzani, P L Caligaris-Cappio, F Seymour, J F Berrebi, A Jäger, U Cazin, B Trneny, M Westermann, A Wendtner, C M Eichhorst, B F Staib, P Bühler, A Winkler, D Zenz, T Böttcher, S Ritgen, M Mendila, M Kneba, M Döhner, H Stilgenbauer, S Producer: 20101019 In: Lancet (London, England) vol. 376 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)